Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Anal Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
9 drugs · 24 active trials
0 drugs · 0 active trials
no drug at this stage
0 drugs · 0 active trials
no drug at this stage
Data updated 8 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Nivolumab | Phase 3 | Phase 3 | 6 | 0 | 2 | 7 | 0 | — | — | May 13, 2015 |
| Mitomycin | Phase 3 | Phase 3 | 5 | 2 | 6 | 15 | 0 | — | — | 1998-10 |
| Capecitabine | Phase 3 | Phase 3 | 5 | 2 | 2 | 10 | 0 | — | — | 2004-04 |
| Fluorouracil | Phase 3 | Phase 3 | 3 | 1 | 6 | 21 | 0 | — | — | 1998-10 |
| Carboplatin | Phase 3 | Phase 3 | 2 | 1 | 1 | 5 | 0 | — | — | 2013-11 |
| Paclitaxel | Phase 3 | Phase 3 | 2 | 1 | 1 | 5 | 0 | — | — | 2013-11 |
| Sintilimab | Phase 3 | Phase 3 | 1 | 1 | 1 | 1 | 0 | — | — | Mar 17, 2026 |
| Cisplatin | Phase 3 | Phase 3 | 0 | 0 | 4 | 10 | 0 | — | — | 1998-10 |
| Imiquimod | Phase 3 | Phase 3 | 0 | 0 | 1 | 1 | 0 | — | — | Sep 24, 2014 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.